- £280.71m
- £288.74m
- £73.28m
- 73
- 13
- 55
- 42
2019 October 31st | R2020 October 31st | 2021 October 31st | 2022 October 31st | 2023 October 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 65.5 | 57.3 | 62.2 | 66.2 | 73.3 |
Cost of Revenue | |||||
Gross Profit | 46 | 42.5 | 45.1 | 51.1 | 57.2 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 63.8 | 53.3 | 54.5 | 57.5 | 63.9 |
Operating Profit | 1.68 | 3.99 | 7.64 | 8.66 | 9.34 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | -0.025 | 1.81 | 7.27 | 6.6 | 7.82 |
Provision for Income Taxes | |||||
Net Income After Taxes | -1.22 | 0.477 | 6.03 | 5.61 | 5.58 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Extraordinary Items | |||||
Net Income | -1.71 | 1.28 | 11.9 | 5.04 | 5.58 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -1.71 | 1.28 | 11.9 | 5.04 | 5.58 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 0.001 | 0.004 | 0.013 | 0.014 | 0.014 |
Dividends per Share |